Original
Original
Original
February 7, 2024
1
Safe Harbor Statement
This presentation and discussion contain forward-looking statements, including our expectations for the future
market for our products, revenues, profits, and other results that are forward-looking statements under the SEC’s
safe harbor provision. These forward-looking statements are based on management’s current expectations and
are subject to the risks inherent in our business. These risks are described in detail in our Form 10-K annual
report and other SEC filings. Our actual events and results may differ materially from our current expectations.
We do not assume any obligation to update these forward-looking statements.
2
Axcelis at a Glance
◼ Global leader in technology development and manufacturing of ion implant systems and services for the semiconductor
industry for 45 years
• Serving the ~$2.7B ion implant systems market
• Based in Beverly, MA with headcount greater than 1700 worldwide
• Global customer support infrastructure
• Growing installed base of greater than 3000 tools
• Strong IP portfolio
◼ Supplier of record to leading semiconductor CAPEX spenders in all market segments including DRAM, NAND, Foundry,
Logic, Power and Image Sensor
3
Axcelis Business Thesis
Axcelis is the implant leader in Only company with a complete family of implant products
the high growth specialty device Strong technical differentiation
market segments Long term customer relationships
4
Q4 2023/FY 2023 Highlights & Summary
◼ Record fourth quarter and full year 2023 financial performance
• Record Revenue of $310.3M/$1.13B and strong EPS of $2.15/$7.43
• Record system revenue of $241.8M/$883.6M
• Record CS&I revenue of $68.5M/$247.0M – driven by increasing Purion installed base
• Gross margin of 44.4%/43.5%
• Year end 2023 cash, cash equivalents and short-term investments of $506.1M
• Year end backlog of $1.2B and solid Q4 bookings of $235.5M
◼ Axcelis expects a similar revenue profile in terms of segment mix and total revenue for 2024, with revenue
weighted to the second half driven by an expected recovery in the general mature segment and the early
stages of a DRAM recovery. This positions the company well to achieve the $1.3B revenue target in 2025.
5
Q4 and FY 2023 Financial Results and Outlook (GAAP)
Q4 2023 FY 2023 Q1 2024 Outlook
Revenue $310.3M $1.13B ~$242M
Gross Margin 44.4% 43.5% ~43.5%
Combined R&D and SG&A Expenses 19.0% 19.9% ~25%2
Operating Profit $79.1 $265.8 ~$45M
Net Income $71.1 $246.3
EPS $2.151 $7.431 ~$1.223
Cash, cash equivalents and
$506.1M
short-term investments
Debt $0
Inventory $306.5M
1. Includes F/X gain of $0.10 for Q4/2023 and loss of $0.01 for FY2023, net of taxes
2. OPEX as a percentage of sales is expected to decline over the course of 2024 given the higher volumes expected in the second half of the year
Projected Investments in R&D will increase in 2024 to approximately 9.5% of revenue, over the 8.6% invested in 2023
3. Assumes 15% tax rate
6
Purion Continues to Drive Axcelis Growth
▪ Quality focused
▪ Great employees
7
Target Business Model (GAAP)
Axcelis revenue grew 23% in 2023 to $1.13B despite the industry downturn
and currently targets revenue of approximately $1.3B in 2025
* The model is not a forecast of results but is intended to be indicative of the annual results Axcelis may achieve based on our strategic objectives
8
Fundamentals Supporting Axcelis Growth Remains Strong
Fundamental growth drivers for long-term cycle
▪ Electrification of the automotive industry with ADAS (Driver Assist) –
“Computer on Wheels”
• Power devices, image sensors and mature devices
Ion Implant Annual TAM Estimates ($B) ◼ Strong TAM growth driven by
$3.5 • Increased overall wafer starts across all segments
$3.0
• Rapid growth of implant capital intensive mature
nodes and specialty devices (implant $/wafer start)
$2.5 — Power and image sensor
$2.0
• High value Purion product extensions required by
specialty markets
$1.5 — Purion Power and Image Sensor Series
$1.0
◼ Mature Process Technology (MPT) market segments
$0.5
account for approximately 70% of the implant TAM
$0.0
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
◼ 2025/2026 TAM increase based on recovery of memory,
Implant Capital Spending ($B)
CIS and general mature market segments
* Data Source: Gartner (July 2022) through 2021, Axcelis TAM Forecast 2022-2026
10
Ion Implant TAM Segment Breakdown
◼ The mature process technology segment
accounts for approximately 70% of the ion
implant TAM Mature Process Technology – 71% Memory – 16% Advanced Logic - 13%
SiC Device Market Growth Dominated by Automotive SiC Wafer Starts Projected to Double Every 3 Years
7,000 2,500
2,000
5,000
1,500
4,000
>30% CAGR
3,000
1,000
2,000
500
1,000
0 0
2021 2027 2022 2023 2024 2025 2026 2027
13 Source: Yole 2020, Yole April 2022 and Axcelis Internal Estimates July 2022
Axcelis Power Device Revenue Growth*
SiC Growth Accelerates Fueled by Automotive
14
Purion Power Series Revenue Growth*
Driving Customer Success in Manufacturing SiC Power Devices
Purion Power Series
• Providing full recipe coverage for all
power device applications
• Enabling high volume manufacturing
and device optimization
• Reducing customer Cost of Ownership
Purion M
SiC
Purion Purion
H200 XE/EXE
2019 2020 2021 2022 2023 2024(E)
SiC SiC
Purion M SiC Purion H200 SiC Purion XE/EXE SiC
* The chart is not a forecast of results but is intended to be indicative of results Axcelis may achieve based on our strategic objectives
15
Purion Power Series
Optimizing SiC and Si Power Device Performance
SiC Trench MOSFET Power Device
Purion H200, Purion H200 SiC
Purion H200 SiC
Purion M
Purion M SiC
Purion M SiC
Purion
XE/EXE SiC
Purion H
Si IGBT Power Device
Purion H200
Trend
Purion M
Purion XE, EXE
Purion XE SiC, EXE SiC
Purion H
Purion XE
16
Purion – The Core of Our Growth Strategy
Targeted Market Segments
◼ Geographic expansion
• China emphasis on mature process technology for a large, diverse group of customers
• Japan focus on power devices, image sensors and NAND
18
Accelerated Purion Systems Evaluation Activity
◼ Eight Purion evaluation systems currently in the field
• Located at strategic customer sites in key market segments
◼ Continued successful evaluations of new products in key markets will drive Axcelis growth
• Purion Dragon to R&D fab at leading memory and advanced logic manufacturer
• Purion H200 SiC evaluations will enable silicon carbide customers to prepare for production volume ramps and to
optimize device performance earlier
Total Systems 1 1 4 1 1 8
19
Key Purion Placements in Target Segments
Supporting Long Term Revenue Growth and Margin Expansion
AXCELIS ANNOUNCES MULTIPLE SHIPMENTS OF PURION Axcelis Announces Shipment of Purion Dragon High Current
POWER SERIES IMPLANTERS TO LEADING SILICON CARBIDE Implanter to a World-Leading Research and Innovation Center
CHIPMAKERS WORLDWIDE AXCELIS ANNOUNCES SHIPMENT OF
PURION H200 SIC POWER SERIES IMPLANTER TO WOLFSPEED The System Will be Used in Sub 3 Nanometer
BEVERLY, Mass., July 11, 2023-- Axcelis Technologies, Inc. Logic Device Development
(Nasdaq: ACLS), a leading supplier of enabling ion implantation BEVERLY, Mass., and DURHAM, NC, July 26, 2023-- Axcelis
solutions for the semiconductor industry, today announced multiple Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion
BEVERLY, Mass., Oct. 10, 2023 -- Axcelis Technologies, Inc. (Nasdaq:
shipments of the Purion Power Series ion implanter systems to implantation solutions for the semiconductor industry, today
ACLS), a leading supplier of innovative, high-productivity solutions for the
leading silicon carbide (SiC) power device chipmakers worldwide. announced a shipment of a Purion H200 SiC ion implant system to
semiconductor industry, announced today a shipment of the Purion Dragon
The shipments, all delivered in the second quarter, included a Purion Wolfspeed, a global leader in silicon carbide technology. The
high current implanter to a world-leading research and innovation center in
H200 SiC evaluation system for a leading SiC power device evaluation system will be used to support the production of power
nanoelectronics and digital technologies located in Europe. The system will
manufacturer in the United States as well as multiple revenue devices for electric vehicle (EV) applications. .
be used in technology development for advanced logic devices. The system
systems for customers in Asia. shipped in the third quarter of 2023.
20
Rapid Manufacturing and Supply Chain Growth
Enabled by Smart Capacity Planning and Execution
Beverly MA Headquarters Beverly Logistics Center Axcelis Asia Operations Center in South Korea
◼ Numerous capital projects and ◼ Beverly logistics center opened ◼ Axcelis Asia Operations Center in
kaizen events in place to increase in Q3/2023 and is fully functional South Korea celebrates 2nd year of
revenue dollars per square foot providing significant efficiencies production at the end of 2023
of space at our Beverly site to US manufacturing
◼ More than $300M of systems
◼ Investing in our next phase of shipped from the AAOC in it’s first
lean manufacturing with two years of operation
augmented reality and AI to
improve productivity and
capacity
21
Methodical Program-Driven Gross Margin Improvement
Margin Improvement Fueled by Reduction in Cost of Goods and Higher Purion Product Extension and CS&I Revenues
22
Margin Improvement of Purion Products
Improves Overall Gross Margin and Reduces Mix-Induced Variability
Purion System Margin
• Closely work with supply chain partners to ensure on time delivery. Added additional resources and qualified new
suppliers in bottleneck areas
• Working with freight providers to add extra shipping lanes. Will take advantage of our new Korean factory to
improve material flow
• Strengthened our logistics team and will continue to remain focused on delivery and lowering shipping costs
• Ongoing review of MRP lead times, enabling timely adjustments to ensure ability to meet customer requirements
• Buffering supply chain disruptions with inventory. Plan to continue to carry a higher than required level of inventory
until we see sustained improvement across the supply chain
24
Customer Solutions & Innovation (CS&I)
Drives Margin Growth and Customer Satisfaction
◼ Significant contributor to Axcelis financials
• Expected to contribute approximately 25% of total revenues
• Accretive to Axcelis corporate gross margins
◼ Committed to investment in CS&I to drive financial growth and increased customer satisfaction levels
• Continuous organizational development and performance improvement through training, certification, and hiring
• Innovative service offering ”Digital Tool Box” – online training, remote diagnosis and install, and automated
troubleshooting guide
— Software licensing for advanced features
— Data analytics to drive self testing and predictive maintenance
25
Investing in Products, Infrastructure and Employees to Drive Growth
◼ Axcelis has heavily focused R&D spending on Purion product development. Many new products and extensions have
been released and shipped to numerous first time and existing customers
◼ We will continue to invest R&D dollars on new Purion product extensions, CIP, field upgrades and new technologies
◼ Investing across the company to strengthen our business processes, capabilities and employee talent
• Upgrading many IT enterprise systems with new technology
• Focusing on software automation in several support areas
• Investing in employee development and training
• Continuing to align employee compensation with benchmark data
◼ Spending will be aligned with initiatives that fuel revenue growth and gross margin expansion
26
ESG at Axcelis
◼ Environmental
• Founding Member of Semiconductor Climate Consortium
• Committed to Science Based Targets and the path to Net Zero by 2050
• Reported Global Scope 1 and Scope 2 CO2e emissions through Carbon Disclosure Project
• Sourcing 100% of electricity for WHQ from Renewable Hydro Generation
◼ Social
• Supporting an inclusive community through DEIB initiatives and a women’s ERG
• In 2022, % of women in the US workforce increased by 6.5% and non-white, non-Asian US
employees grew by 35.5%
• 162 employees participated in leadership training since 2021
• Increased tuition reimbursement program up to $15K annually
• Axcelis Cares charitable program active in our communities
◼ Governance
• Committed to ethical standards and legal compliance
• Axcelis Board has three female directors and two male directors of Asian and Hispanic
ethnicities
• Axcelis has a long history of best practice governance policies
27
For more details refer to our 2023 ESG Report and our ESG Document Hub.
Axcelis Capital Allocation Strategy
◼ The company will continue to maintain a strong and healthy Quarterly Diluted Share Count
balance sheet while investing in initiatives that are expected to 35
drive strong revenue growth and gross margin expansion
programs
28
Axcelis Business Thesis
Axcelis is the implant leader in Only company with a complete family of implant products
the high growth specialty device Strong technical differentiation
market segments Long term customer relationships
29
Axcelis Technologies, Inc
Nasdaq - ACLS
30